Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    michaelson
Show Display Options
Rank Status Study
1 Recruiting Tivozanib + Enzalutamide in Adv Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Tivozanib;   Drug: Enzalutamide
2 Recruiting Individually Tailored Web-based Multimodal Pain Rehabilitation in Primary Health Care
Condition: Musculoskeletal Pain
Intervention: Behavioral: Web-based multimodal rehabilitation based on cognitive based principles
3 Completed
Has Results
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: ET 743
4 Completed
Has Results
Study of SU11248 in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Sunitinib
5 Completed Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Condition: Cancer
Intervention:
6 Completed Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: paclitaxel;   Biological: trastuzumab;   Radiation: radiation therapy
7 Active, not recruiting Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Neoplasm Metastases
Interventions: Drug: Gemcitabine;   Drug: Sunitinib
8 Withdrawn Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Sunitinib;   Drug: Bevacizumab
9 Active, not recruiting Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
10 Recruiting Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Condition: Pulmonary Arterial Hypertension
Intervention:
11 Recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Positive;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Systemic Chemotherapy;   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Exemestane;   Drug: Letrozole;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment

Indicates status has not been verified in more than two years